CEVA / Ceva drops appeal over French bird flu vaccine tender

Some under-the-radar AI stocks are poised to be the AI leaders of tomorrow. The AI sector is filled with cyclical businesses, and some stocks are curr more_horizontal

French animal health group Ceva has withdrawn a legal challenge over a tender to supply France with a bird flu vaccine in which Ceva lost out to Germa more_horizontal

Ceva (CEVA) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.12. This compares to earnings of $0.18 per shar more_horizontal

CEVA, Inc. (NASDAQ:CEVA ) Q4 2022 Earnings Conference Call February 15, 2023 8:30 AM ET Company Participants Richard Kingston - Vice President, Market more_horizontal

Ceva (CEVA) delivered earnings and revenue surprises of 35.29% and 3.18%, respectively, for the quarter ended December 2022. Do the numbers hold clues more_horizontal

Many everyday devices utilize Ceva's wireless and smart sensing technology. more_horizontal

The stock has been on fire lately, but a look at the charts suggests there are obstacles ahead that could potentially block further gains. Growth seem more_horizontal

Ceva (CEVA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock more_horizontal